Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS). Several therapies for it exist,...

Multiple sclerosis can cause a variety of symptoms varying significantly in severity and progression among individuals: changes in sensation (hypoesthesia)...

Tumefactive multiple sclerosis is a condition in which the central nervous system of a person has multiple demyelinating lesions with atypical characteristics...

Multiple sclerosis (MS) is an autoimmune disease resulting in damage to myelin – the insulating covers of nerve cells – in the brain and spinal cord....

Malignant multiple sclerosis is used to describe MS patients who reach significant level of disability in a short period of time. Malignant MS cases are...

diagnosing multiple sclerosis (MS) are based on the 2018 revision of McDonald criteria. They rely on MRI detection (or clinical demonstration) of demyelinating...

The National Multiple Sclerosis Society (NMSS) is an American nonprofit organization founded in 1946. It is an organization dedicated to supporting individuals...

effectiveness of TENS in relation to pain management of multiple sclerosis (MS). MS is a chronic autoimmune neurological disorder, which consists of the demyelination...

There are several ways for pharmaceuticals for treating multiple sclerosis (MS) to reach the market. Novel pharmaceuticals cannot enter the US market without...

from Multiple Sclerosis, but considered by others to form a spectrum differing only in terms of chronicity, severity, and clinical course. Multiple sclerosis...

The Multiple Sclerosis Trust (MS Trust) is an independent, national UK charity that was established in 1993. The MS Trust works to provide information...

Tuberous sclerosis complex (TSC) is a rare multisystem autosomal dominant genetic disease that causes non-cancerous tumours to grow in the brain and on...

Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND) or—in the United States—Lou Gehrig's disease (LGD), is a rare, terminal...

Charge detection mass spectrometry Clinical Data Management System Clinically Definite Multiple Sclerosis Cryogenic Dark Matter Search This disambiguation...

similar to aggressive forms of multiple sclerosis. Although historically considered rare, with fewer than 1% of multiple sclerosis cases showing the characteristic...

(1909–2008), academic neurologist at the University of Oregon, for the treatment of multiple sclerosis. The claims made for the diet are unsubstantiated...

occasionally used in the management of multiple sclerosis (MS), because anecdotal reports indicated a positive effect (reversal of symptoms) of a GFD in MS patients...

S, Levesque H (2008). "Watermelon stomach in systemic sclerosis: its incidence and management". Alimentary Pharmacology & Therapeutics. 28 (4): 412–421...

investigational RIPK1 inhibitor that may be useful in the management of multiple sclerosis. An autoinflammatory disease characterised by recurrent fevers...

bowel diseases (such as Crohn's disease and ulcerative colitis), multiple sclerosis, alopecia areata, Addison's disease, pernicious anemia, psoriasis...

consists of a mixture of histamine and caffeine. It is marketed as a treatment for fatigue in multiple sclerosis (MS), although in the 1950s multiple sclerosis...

treatment for relapsing-remitting multiple sclerosis (RRMS) under the brand name Nerventra. Management of multiple sclerosis Tan IL, Lycklama à Nijeholt GJ...

neuralgia caused by multiple sclerosis (MS). This normally indicates problems with both trigeminal nerves, since one nerve serves the left side of the face and...

the first Chairman of the Multiple Sclerosis section of the American Academy of Neurology (AAN) and recognized as a multiple sclerosis clinician. Miller...

Oligoclonal bands are present in the CSF of more than 95% of patients with clinically definite multiple sclerosis. Two methods of analysis are possible: (a) protein...

beta 1-alpha) is a cytokine in the interferon family used to treat multiple sclerosis (MS). It is produced by mammalian cells, while interferon beta-1b...

optica (NMO), Balo concentric sclerosis and Marburg multiple sclerosis. Symptoms are similar to those in multiple sclerosis and may include dementia, aphasia...

Gilenya, is an immunomodulating medication, used for the treatment of multiple sclerosis. Fingolimod is a sphingosine-1-phosphate receptor modulator, which...

mechanisms, and treatment of multiple sclerosis (MS), most notably the development of B cell therapies for MS patients, a powerful class of therapeutics that...

the brand name Tysabri among others, is a medication used to treat multiple sclerosis and Crohn's disease. It is a humanized monoclonal antibody against...